Multiple sclerosis risk gene Mertk is required for microglial activation and subsequent remyelination
Summary: In multiple sclerosis (MS) and other neurological diseases, the failure to repair demyelinated lesions contributes to axonal damage and clinical disability. Here, we provide evidence that Mertk, a gene highly expressed by microglia that alters MS risk, is required for efficient remyelinatio...
Main Authors: | Kimberle Shen, Mike Reichelt, Roxanne V. Kyauk, Hai Ngu, Yun-An A. Shen, Oded Foreman, Zora Modrusan, Brad A. Friedman, Morgan Sheng, Tracy J. Yuen |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-03-01
|
Series: | Cell Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211124721001492 |
Similar Items
-
Mechanisms of remyelination: recent insight from experimental models
by: Tanaka Tatsuhide, et al.
Published: (2014-08-01) -
PDGF and FGF2 pathways regulate distinct oligodendrocyte lineage responses in experimental demyelination with spontaneous remyelination
by: Joshua C. Murtie, et al.
Published: (2005-06-01) -
Particles Containing Cells as a Strategy to Promote Remyelination in Patients With Multiple Sclerosis
by: Jorge Matías-Guiu, et al.
Published: (2020-07-01) -
Emerging Cellular and Molecular Strategies for Enhancing Central Nervous System (CNS) Remyelination
by: Mohammad Abu-Rub, et al.
Published: (2018-06-01) -
Butyrate suppresses demyelination and enhances remyelination
by: Tong Chen, et al.
Published: (2019-08-01)